Mrs. Nicole Santillo, MA CCC SLP TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1953 State Route 302, Circleville, NY 10919 Phone: 845-744-2031 |
Emily Beck Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Ny Route 302, Circleville, NY 10919 Phone: 845-744-2031 |
News Archive
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2010.
Most cancer tissues are invaded by inflammatory cells that either stimulate or inhibit the growth of the tumor, depending on what immune cells are involved. Now a Swedish-Belgian research team has shown that a protein that naturally occurs in the body, HRG, inhibits tumor growth and metastasis into secondary organs by activating specific immune cells.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
New research reveals a high-resolution view of the Zika viral life cycle within infected cells and shows dramatic changes in the cell's architecture throughout the infection process. This novel perspective may lead to the development of new vaccines and treatments.
› Verified 8 days ago